Global Nanomedicine Market Projected to be Worth USD 177.60 Billion by 2019: Transparency Market Research
Summary
Albany, NY, March 30, 2014 --( Please visit: http://www.transparencymarketresearch.com/nanomedicine-market.html The new title on “Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," predicts that the total nanomedicine market globally will be worth USD 177.60 billion by 2019, growing considerably from its 2012 value of USD 78.54 billion.The development of nanomedicine-based treatments and products that are able to directly target tumors in the brain and other bodily sites is poised to be a significant factor affecting growth in this market.Factors that are likely to cause this increased growth rate include: an improvement in the regulatory framework as well as the presence of a wide-ranging product portfolio in the pipeline, set to be introduced by leading market players.These key market players include names such as: Abbott Laboratories, Merck & Co Inc, Pfizer Inc., GE Healthcare, Nanosphere Inc., and many more.These factors are collectively anticipated to further fuel the growth of the cardiovascular segment within the nanomedicine market.The report also carries out an in-depth analysis of the regional market share based on the applications, revenue, and products.